- •Burn Care and Treatment
- •Contents
- •1.1 Initial Assessment and Emergency Treatment
- •Box 1.1. Primary and Secondary Survey
- •1.2 Fluid Resuscitation and Early Management
- •1.2.1 Fluid Resuscitation
- •1.2.2 Endpoint of Burn Resuscitation
- •1.2.4 Role of Colloids, Hypertonic Saline, and Antioxidants in Resuscitation
- •1.2.4.1 Colloids
- •1.2.4.2 Hypertonic Saline
- •1.2.4.3 Antioxidants: High-Dose Vitamin C
- •1.3 Evaluation and Early Management of Burn Wound
- •1.3.1 Evaluation of Burn Depth
- •1.3.2 Choice of Topical Dressings
- •1.3.3 Escharotomy
- •1.3.4 Operative Management
- •References
- •2: Pathophysiology of Burn Injury
- •2.1 Introduction
- •2.2 Local Changes
- •2.2.1 Temperature and Time Effect
- •2.2.2 Etiology
- •2.2.3 Pathophysiologic Changes
- •2.2.4 Burn Size
- •2.3 Systemic Changes
- •2.3.1 Edema Formation
- •2.3.3.1 Resting Energy Expenditure
- •2.3.3.2 Muscle Catabolism
- •2.3.3.3 Glucose and Lipid Metabolism
- •2.3.4 Renal System
- •2.3.5 Gastrointestinal System
- •2.3.6 Immune System
- •2.4 Summary and Conclusion
- •References
- •3: Wound Healing and Wound Care
- •3.1 Introduction
- •3.2 Physiological Versus Pathophysiologic Wound Healing
- •3.2.1 Transforming Growth Factor Beta
- •3.2.2 Interactions Between Keratinocytes and Fibroblasts
- •3.2.3 Matrix Metalloproteinases (MMP)
- •3.3.1 Burn Wound Excision
- •3.3.2 Burn Wound Coverage
- •3.3.3 Autografts
- •3.3.4 Epidermal Substitutes
- •3.3.5 Dermal Substitutes
- •3.3.6 Epidermal/Dermal Substitutes
- •3.4 Summary
- •References
- •4: Infections in Burns
- •4.1 Burn Wound Infections
- •4.1.1 Diagnosis and Treatment of Burn Wound Infections
- •4.1.1.1 Introduction
- •4.1.2 Common Pathogens and Diagnosis
- •4.1.3 Clinical Management
- •4.1.3.1 Local
- •4.1.3.2 Systemic
- •4.1.4 Conclusion
- •4.4 Guidelines for Sepsis Resuscitation
- •References
- •5: Acute Burn Surgery
- •5.1 Introduction
- •5.2 Burn Wound Evaluation
- •5.3 Escharotomy/Fasciotomy
- •5.4 Surgical Burn Wound Management
- •5.5.1 Face
- •5.5.2 Hands
- •5.6 Treatment Standards in Burns Larger Than Sixty Percent TBSA
- •5.7 Temporary Coverage
- •5.9.1 Early Mobilisation
- •5.9.2 Nutrition and Anabolic Agents
- •Bibliography
- •6.1 Introduction
- •6.2 Initial and Early Hospital Phase
- •6.2.1 Blood Pressure
- •6.2.1.1 Resuscitation
- •6.2.1.2 Albumin
- •6.2.1.3 Transfusion
- •6.2.1.4 Vasopressors
- •6.2.2 Urine Output
- •6.2.4 Respiration
- •6.2.4.1 Ventilation Settings
- •6.2.5 Inhalation Injury
- •6.2.6 Invasive and Noninvasive Thermodilution Catheter (PiCCO Catheter)
- •6.2.7 Serum Organ Markers
- •6.3 Later Hospital Phase
- •6.3.1 Central Nervous System
- •6.3.1.1 Intensive Care Unit-Acquired Weakness
- •6.3.1.2 Thermal Regulation
- •6.3.2 Heart
- •6.3.3 Lung
- •6.3.3.1 Ventilator-Associated Pneumonia
- •6.3.4 Liver/GI
- •6.3.4.1 GI Complications/GI Prophylaxis/Enteral Nutrition
- •6.3.4.2 Micronutrients and Antioxidants
- •6.3.5 Renal
- •6.3.6 Hormonal (Thyroid, Adrenal, Gonadal)
- •6.3.7 Electrolyte Disorders
- •6.3.7.1 Sodium
- •6.3.7.2 Chloride
- •6.3.7.3 Phosphate and Magnesium
- •6.3.7.4 Calcium
- •6.3.8 Bone Demineralization and Osteoporosis
- •6.3.9 Coagulation and Thrombosis Prophylaxis
- •Conclusion
- •References
- •7.1 Introduction
- •7.2.1 Glucose Metabolism
- •7.2.2 Fat Metabolism
- •7.2.3 Protein Metabolism
- •7.3 Attenuation of the Hypermetabolic Response
- •7.3.1.1 Nutrition
- •Nutritional Route
- •Initiation of Nutrition
- •Amount of Nutrition
- •Composition of Nutrition (Table 7.1)
- •7.3.1.2 Early Excision
- •7.3.1.3 Environmental Support
- •7.3.1.4 Exercise and Adjunctive Measures
- •7.3.2 Pharmacologic Modalities
- •7.3.2.1 Recombinant Human Growth Hormone
- •7.3.2.2 Insulin-Like Growth Factor
- •7.3.2.3 Oxandrolone
- •7.3.2.4 Propranolol
- •7.3.2.5 Insulin
- •7.3.2.6 Metformin
- •7.3.2.7 Other Options
- •7.4 Summary and Conclusion
- •References
- •8.1 Introduction
- •8.2 Knowledge Base
- •8.2.1.1 Incidence
- •8.3 Aetiology and Risk Factors
- •8.3.1 Pathophysiology
- •8.3.1.1 Severity Factors
- •Box 8.1. Burn Severity Factors
- •8.3.2 Local Damage
- •8.3.3 Fluid and Electrolyte Shifts
- •8.4 Cardiovascular, Gastrointestinal and Renal System Manifestations
- •8.4.1 Types of Burn Injuries
- •8.4.1.1 Clinical Manifestations
- •Box 8.2. Primary Survey Assessment
- •Box 8.3. Signs and Symptoms of Hypovolemic Shock
- •Box 8.4. Physical Findings of Inhalation Injury
- •Box 8.5. Signs and Symptoms of Vascular Compromise
- •Box 8.6. Secondary Survey Assessment
- •8.5 Clinical Management
- •8.5.1 Nonsurgical Care
- •Box 8.7. Secondary Survey Highlights
- •Box 8.8. First Aid Management at the Scene
- •Box 8.9. Treatment of the Severely Burned Patient on Admission
- •Box 8.10. Fluid Resuscitation Using the Parkland (Baxter) Formula
- •Box 8.11. Properties of Topical Antimicrobial Agents
- •Box 8.12. Criteria for Burn Wound Coverings
- •8.5.2 Surgical Care
- •8.5.3 Pharmacological Support
- •8.5.4 Psychosocial Support
- •References
- •9.1 Electrical Injuries
- •9.1.1 Introduction
- •9.1.2 Diagnosis and Management
- •9.2 Chemical Burns
- •9.3 Cold Injury (Frostbite)
- •References
- •10.1 Introduction
- •10.2 Pathophysiology
- •10.3 Scarring
- •10.4 Therapy
- •10.5 Psychological Aspects
- •10.6 Return to Work
- •10.8 Exercise
- •10.9 Summary
- •References
- •11: Burn Reconstruction Techniques
- •11.1 From the Reconstructive Ladder to the Reconstructive Elevator
- •11.2 The Reconstructive Clockwork
- •11.2.1 General Principles
- •11.3 Indication and Timing of Surgical Intervention
- •11.4 The Techniques of Reconstruction
- •11.4.1 Excision Techniques
- •11.4.1.1 W-Plasty and Geometric Broken Line Closure
- •11.4.2 Serial Excision and Tissue Expansion
- •11.4.3 Skin Grafting Techniques
- •11.4.4 Local Skin Flaps
- •11.4.4.1 Z-Plasty
- •11.4.4.2 Double Opposing Z-Plasty
- •11.4.4.3 ¾ Z-plasty or half-Z
- •11.4.4.4 Musculocutaneous (MC) or Fasciocutaneous (FC) Flap Technique
- •11.4.5 Distant Flaps
- •11.4.5.1 Free Tissue Transfer
- •11.4.5.2 Perforator Flaps
- •11.4.6 Composite Tissue Allotransplantation
- •11.4.7 Regeneration: Tissue Engineering
- •11.4.8 Robotics/Prosthesis
- •11.5 Summary
- •References
- •Appendix
- •Sedatives and Pain Medications
- •Index
7 Nutrition and Hypermetabolic Response Post-Burn |
93 |
|
|
oxygen consumption, and metabolic rate as well as impaired glucose tolerance associated with its hyperglycemic state.
2.The metabolic response then gradually increases within the first 5 days postinjury to a plateau phase and then to flow phase, which is characteristically associated with hyperdynamic circulation and the above-mentioned hypermetabolic state. Insulin release during this time period was found to be twice that of controls in response to glucose load [20, 21], and plasma glucose lev-
els are markedly elevated, indicating the development of an insulin resistance [22, 23]. In addition, lipolysis is tremendously increased leading to increased free fatty acids and triglycerides. Current understanding has been that these metabolic alterations resolve soon after complete wound closure. However, recent studies found that the hypermetabolic response to burn injury lasts significantly longer; we found in recent studies that sustained hypermetabolic alterations post-burn, indicated by persistent elevations of total urine cortisol levels, serum cytokines, catecholamines, and basal energy requirements, were accompanied by impaired glucose metabolism and insulin sensitivity that persisted for up to 3 years after the initial burn injury [24]. These results indicate the importance of long-term follow-up and treatment of severely burned patients.
Post-burn hypermetabolism is initiated to provide sufficient energy for maintaining organ function and whole body homeostasis under demanding trauma conditions [25–28]. Unfortunately, prolonged hypermetabolism becomes detrimental and is associated with vast catabolism, multiorgan failure, and death [1, 29, 30]. Various studies have found that the metabolic need of a burn patient is the highest of any medical state, approaching 140 % of that predicted. The hypermetabolic response involves a vast number of pathways, but there are two, in particular, that appear to most profoundly affect post-burn outcomes: glucose metabolism with insulin resistance (IR) and hyperglycemia [31–34] as well as lipid metabolism with increased lipolysis [35–38].
7.2.1Glucose Metabolism
During the early post-burn phase, hyperglycemia occurs as a result of an increased rate of glucose appearance, along with an impaired tissue extraction of glucose, leading to an overall increase of glucose and lactate [28, 39]. Of major importance is recent evidence strongly suggesting that hyperglycemia is detrimental and associated with adverse clinical outcomes in severely burned patients. Specifically, studies in burn patients indicated that hyperglycemia is associated with increased infections and sepsis, increased incidence of pneumonia, significantly increased catabolism and hypermetabolism, and, most importantly, with increased post-burn mortality [31–34, 40, 41]. The evidence that hyperglycemia is detrimental in burn patients was further supported by a prospective randomized trial that showed that glucose control is beneficial in terms of post-burn morbidity and organ function [34]. Retrospective cohort studies further confirmed a survival benefit of glucose control in severely burned patients [33, 41]. These data strongly indicate that IR and
94 |
M.G. Jeschke |
|
|
hyperglycemia represent a significant clinical problem in burn patients and are clearly associated with poor outcome.
Although the dire consequences of burn-induced hyperglycemia have been delineated, the molecular mechanisms underlying IR and hyperglycemia are not entirely defined. Accordingly, ER stress was recently identified as one of the central intracellular stress signaling pathways linking IR, hyperglycemia, and inflammation [42]. Since inflammation, IR, and hyperglycemia are central characteristics of the post-burn response [3], we investigated in a preliminary study whether a severe burn induces ER stress and the unfolded protein response (UPR) in severely burned patients. As expected, we found that a severe thermal injury induces ER stress in the metabolically active tissues skin, fat, and muscle [43]. We therefore have evidence suggesting that ER stress may be central to orchestrating and inducing inflammatory and hypermetabolic responses post-burn on a cellular level.
7.2.2Fat Metabolism
The other metabolic pathway that is significantly altered during the post-burn hypermetabolic response is lipid metabolism, which may be related to changes in insulin resistance. Lipolysis consists of the breakdown (hydrolysis) of triacylglycerol into free fatty acids (FFA) and glycerol. Notably, lipolysis and free fatty acids not only contribute to post-burn morbidity and mortality by fatty infiltration of various organs, but it was also shown that FFAs can mediate insulin resistance [44]. Specifically, FFAs impair insulin-stimulated glucose uptake [45, 46] and induce insulin resistance through inhibition of glucose transport activity [47]. In the context of type 2 diabetes, it has been shown that increased FFA levels are predictive for incidence and severity of the disease [48]. One of the major alterations post-burn is significantly increased lipolysis, and several studies have suggested that increased lipolysis can be attributed to increased catecholamine levels [49, 50]. Interestingly, despite increased lipolysis, plasma FFA concentrations can be increased or decreased which can be due to hypoalbuminemia or increased intracellular FFA turnover, which is part of the futile cycle involving the breakdown of adipose and muscle TGs into FFA. Regardless, increased triglycerides and FFA lead to fatty infiltration of vital organs, especially the liver. Accordingly, fatty liver is very common post-burn and is associated with increased clinical morbidities, as well as metabolic alterations. Post-burn pathology examinations [51, 52] and spectroscopy studies have shown that burned children have a three to fivefold increase in hepatic triglycerides [53, 54], associated with increased incidence of infection, sepsis, and poor outcome [38]. In addition, hepatic triglyceride levels were higher than those found in diabetic elderly patients, underscoring the metabolic link between fatty infiltration and insulin resistance. This data is in agreement with various other recent studies that showed a strong relationship between fat and glucose metabolism [55]. Though this relationship is clear, the mechanism by which lipids induce insulin resistance is not entirely defined.